Mitch C. Hill - 12 Apr 2023 Form 4 Insider Report for Inari Medical, Inc.

Role: Chief Financial Officer
Signature: /s/ Angela Ahmad, attorney-in-fact for Mitch C. Hill
Issuer symbol: N/A
Transactions as of: 12 Apr 2023
Net transactions value: -$816,462
Form type: 4
Filing time: 14 Apr 2023, 16:44:06 UTC
Previous filing: 04 Apr 2023
Next filing: 16 May 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NARI	Common Stock	Options Exercise	$2,970	+6,500	+3.5%	$0.4570^*	192,054	12 Apr 2023	Direct	F1
transaction	NARI	Common Stock	Sale	$151,098	-2,398	-1.2%	$63.01	189,656	12 Apr 2023	Direct	F1, F2
transaction	NARI	Common Stock	Sale	$147,982	-2,300	-1.2%	$64.34	187,356	12 Apr 2023	Direct	F1, F3
transaction	NARI	Common Stock	Sale	$65,600	-1,000	-0.53%	$65.60	186,356	12 Apr 2023	Direct	F1, F4
transaction	NARI	Common Stock	Sale	$53,068	-802	-0.43%	$66.17	185,554	12 Apr 2023	Direct	F1, F5
transaction	NARI	Common Stock	Sale	$144,625	-2,296	-1.2%	$62.99	183,258	12 Apr 2023	Direct	F1, F6
transaction	NARI	Common Stock	Sale	$146,851	-2,281	-1.2%	$64.38	180,977	12 Apr 2023	Direct	F1, F7
transaction	NARI	Common Stock	Sale	$43,066	-658	-0.36%	$65.45	180,319	12 Apr 2023	Direct	F1, F8
transaction	NARI	Common Stock	Sale	$67,142	-1,015	-0.56%	$66.15	179,304	12 Apr 2023	Direct	F1, F9
holding	NARI	Common Stock						1,600	12 Apr 2023	By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NARI	Stock Options (Right to Buy)	Options Exercise	$0	-6,500	-4.2%	$0.000000	146,477	12 Apr 2023	Common Stock	6,500	$0.4570	Direct	F1, F10

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id	Content
F1	The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022.
F2	This transaction was executed in multiple trades at prices ranging from $62.61 to $63.53. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3	This transaction was executed in multiple trades at prices ranging from $63.84 to $64.76. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4	This transaction was executed in multiple trades at prices ranging from $65.10 to $66.09. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5	This transaction was executed in multiple trades at prices ranging from $66.12 to $66.28. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F6	This transaction was executed in multiple trades at prices ranging from $62.62 to $63.44 The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F7	This transaction was executed in multiple trades at prices ranging from $63.84 to $64.82 The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F8	This transaction was executed in multiple trades at prices ranging from $65.00 to $65.94. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F9	This transaction was executed in multiple trades at prices ranging from $66.04 to $66.26. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F10	Options vested with respect to 25% of the shares on April 30, 2020 and vest with respect to the remaining shares in 36 equal monthly installment thereafter.